Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dietary Management

- PMLiVE

FDA hands GSK a reprieve by blocking Novartis generic

The Advair rival could be delayed until 2019

Working with our healthcare system more closely is vital

Bayer’s Lars Bruening on partnership working amid environmental challenges

Risky business for pharma

China, Russia and Brazil are expected to provide the most issues

Lynch syndrome: a patient perspective

Blue Latitude Health intern Costantino Ciotti gives an insight into life with Lynch Syndrome, a genetic condition associated with colon cancer. Here he explores the patient’s perspective, including treatment options,...

Blue Latitude Health

AI Voice Assistants

Battle of the Voice Assistants and Voice Search

At-a-glance crib sheet on how the battle of the voice assistants is shaping up between Amazon, Google, Apple, Microsoft and Samsung.

An agency called Owen

- PMLiVE

Gilead’s triple HIV drug approval prompts GSK lawsuit

ViiV claims bictegravir infringes its patent estate

- PMLiVE

J&J takes option on Theravance’s JAK drug in $1bn deal

TD-1473 has potential treating ulcerative colitis, Crohn’s and IBD patients

- PMLiVE

W2O bolsters its commercialisation offering

Rita Glaze joins the firm as leader of value, pricing and market access practice

- PMLiVE

Narrative Health appoints a new director

Gillian Newbold joins the team from Healthcare Research Worldwide

It’s only money

Pricing and penalties

- PMLiVE

A Magical Makeover for Lucid Group

Lucid launch their new company branding

Lucid Group Communications Limited

Celgene building

Celgene’s triple multiple myeloma therapy clears phase III trial

The biotech says the combo hit its OPTIMISMM primary endpoint

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links